NICE has increased its capacity for appraising new drugs and treatments, and will be able to review existing NICE appraisals more quickly

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.592, 2009-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NICE result for three drugs . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

NICE recommends four drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer

By Connock Martin  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 827-837

Adis International

Access to resources Recommend Favorite

UK NICE appraisals necessary says chairman

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

NICE issues guidance on new devices, a tPA and cancer drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite